Lung adenocarcinoma - a diagnostic challenge

Submitted: 26 October 2023
Accepted: 2 May 2024
Published: 6 May 2024
Abstract Views: 747
PDF: 67
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Cavitary lung nodules are produced by a variety of diseases ranging from benign to malignant disease. According to the Fleischner Society, the pulmonary cavity is characterized by a gas-filled space, seen as a lucency or low-attenuation area, within pulmonary consolidation, a mass, or a nodule. Though the number and thickness of the wall of the cavity may help to differentiate causes, arriving at a diagnosis is challenging. Even though radiological findings will help to differentiate benign from malignant etiology, histopathology is needed for confirmation of diagnosis. Here, we describe a metastatic lung adenocarcinoma case presenting as multiple cavitary nodules.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Myers DJ, Wallen JM. Lung adenocarcinoma. Available from: https://www.ncbi.nlm.nih.gov/books/NBK519578/
Kim H, Park CM, Koh JM, et al. Pulmonary subsolid nodules: what radiologists need to know about the imaging features and management strategy. Diagn Interv Radiol. 2014;20:47-57. DOI: https://doi.org/10.5152/dir.2013.13223
Detterbeck FC, Marom EM, Arenberg DA, et al. The IASLC Lung Cancer Staging Project: background data and proposals for the application of TNM Staging Rules to lung cancer presenting as multiple nodules with ground glass or lepidic features or a pneumonic type of involvement in the forthcoming eighth edition of the TNM Classification. J Thorac Oncol. 2016;11:666-80. DOI: https://doi.org/10.1016/j.jtho.2015.12.113
Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol. 2015;10:1243-60. DOI: https://doi.org/10.1097/JTO.0000000000000630
Parkar AP, Kandiah P. Differential diagnosis of cavitary lung lesions. J Belg Soc Radiol. 2016;100:100. DOI: https://doi.org/10.5334/jbr-btr.1202
Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6:244-85. DOI: https://doi.org/10.1097/JTO.0b013e318206a221
Chaudhuri MR. Primary pulmonary cavitating carcinomas. Thorax. 1973;28:354-66. DOI: https://doi.org/10.1136/thx.28.3.354
Vishak Acharya K, Unnikrishnan B, Shenoy A, Holla R. Utility of various bronchoscopic modalities in lung cancer diagnosis. Asian Pac J Cancer Prev. 2017;18:1931-6.
Watson WL, Smith RR. Terminal bronchiolar or “alveolar cell” cancer of the lung: report of thirty-three cases. Journal of the American Medical Association. 1951;147:7-13. DOI: https://doi.org/10.1001/jama.1951.03670180013002

How to Cite

Sivaselvi, C., Moorthy, A., Dwivedi, D. P., & Badhe, B. A. (2024). Lung adenocarcinoma - a diagnostic challenge. Chest Disease Reports, 12(1). https://doi.org/10.4081/cdr.12.12032